Adherence to colorectal cancer screening: A randomized clinical trial of competing strategies

Archives of Internal Medicine

Volumn 172, Issue 7, 2012, Pages 575-582

  Inadomi, John M ^a,b,c   Vijan, Sandeep ^d,e   Janz, Nancy K ^f   Fagerlin, Angela ^d,e   Thomas, Jennifer P ^b,c   Lin, Yunghui V ^b,c   Munõz, Roxana ^b,c   Lau, Chim ^b,c   Somsouk, Ma ^b,c   El Nachef, Najwa ^b,c   Hayward, Rodney A ^d,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d Health Services Research and Development Center of Excellence   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CHINESE; CLUSTER ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); URBAN AREA;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PATIENT COMPLIANCE; RISK FACTORS; SIGMOIDOSCOPY;

EID: 84859717249     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.332     Document Type: Article

References (33)

1. Wilson JMG, Jungner F. Principles and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968.
2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040): 1472-1477. (Pubitemid 26400242)
3. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348(9040):1467-1471. (Pubitemid 26400241)
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365-1371. (Pubitemid 23131388)
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-1607. (Pubitemid 32162983)
6. Selby JV, Friedman GD, Quesenberry CPJ Jr, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Intern Med. 1993;118(1):1-6. (Pubitemid 23007964)
7. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84(20): 1572-1575.
8. Selby JV, Friedman GD, Quesenberry CPJ Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653-657.
9. Atkin WS, Edwards R, Kralj-Hans I, et al UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726): 1624-1633.
10. Winawer SJ, Zauber AG, Ho MN, et al The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993; 329(27):1977-1981. (Pubitemid 24015040)
11. Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: a case-control study among veterans. Arch Intern Med. 1995;155 (16):1741-1748.
12. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32,702 veterans. Ann Intern Med. 1995; 123(12):904-910.
13. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-141. (Pubitemid 34779159)
14. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149(9):627-637.
15. Levin B, Lieberman DA, McFarland B, et al American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5): 1570-1595.
16. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [published correction appears in Am J Gastroenterol. 2009 Jun;104(6):1613]. Am J Gastroenterol. 2009;104(3): 739-750.
17. Maxwell AE, Crespi CM, Antonio CM, Lu P. Explaining disparities in colorectal cancer screening among five Asian ethnic groups: a population-based study in California. BMC Cancer. May 19 2010;10:214.
18. Doubeni CA, Laiyemo AO, Klabunde CN, Young AC, Field TS, Fletcher RH. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med. 2010;38(2):184-191.
19. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? a comparison of costs, effectiveness, and compliance. Am J Med. 2001;111 (8):593-601. (Pubitemid 34088068)
20. Heisler M, Cole I, Weir D, Kerr EA, Hayward RA. Does physician communication influence older patients' diabetes self-management and glycemic control? results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci. 2007;62(12):1435-1442. (Pubitemid 351158373)
21. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152(9):1423-1433.
22. Anderson CJ. The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull. 2003;129(1):139-167. (Pubitemid 41103271)
23. Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA. 1995;273(4):302-305.
24. Jones RM, Vernon SW, Woolf SH. Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev. 2010;19(11):2821-2825.
25. Inadomi JM, Kuhn L, Vijan S, Fendrick AM, McMahon LF, Hayward RA. Adherence to competing colorectal cancer screening strategies. Am J Gastroenterol. 2005;100:S387-S388.
26. Segnan N, Senore C, Andreoni B, et al; SCORE2 Working Group-Italy. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst. 2005;97(5):347-357. (Pubitemid 40425953)
27. Segnan N, Senore C, Andreoni B, et al; SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132(7):2304-2312.
28. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082-2091. (Pubitemid 37185810)
29. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100(10):2093-2103. (Pubitemid 38580326)
30. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129-2135. (Pubitemid 41434589)
31. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis. 2001;11(3):496-518. (Pubitemid 33584373)
32. Schwartz B. The Paradox of Choice: Why More Is Less. New York, NY: Ecco; 2004.
33. Iyengar S. The Art of Choosing. New York, NY: Twelve; 2010.